The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease.

Roshanov, Pavel S; Khanna, Reena

Roshanov, Pavel S; Khanna, Reena.

Affiliation

Roshanov PS; Division of Nephrology, Department of Medicine, Western University, London, ON, Canada.
Khanna R; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.

Inflamm Bowel Dis ; 30(1): 156-158, 2024 Jan 05.

Article in En | MEDLINE | ID: mdl-37987647

We review concerns regarding use of placebo in clinical trials of inflammatory bowel disease. We propose alternate designs to overcome ethical issues, while providing data that are clinically relevant.

Subject(s)

Colitis, Ulcerative; Inflammatory Bowel Diseases; Humans; Inflammatory Bowel Diseases/drug therapy; Colitis, Ulcerative/drug therapy

Key words

Crohn's disease; inflammatory bowel disease; placebo; trial design; ulcerative colitis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google